{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["ClueGO Results Wikipathways"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"ClueGO Results Wikipathways","index":0,"n_rows":48,"n_cols":12,"rows_kept":48,"flags":["formulas_cached_only"]}
["GOID","GOTerm","Ontology Source","Term PValue","Term PValue Corrected with Bonferroni step down","Group PValue","Group PValue Corrected with Bonferroni step down","GOLevels","GOGroups","% Associated Genes","Nr. Genes","Associated Genes Found"]
["WP:2431","Spinal Cord Injury","WikiPathways_27.02.2019",3.651494487380519e-07,5.112092282332727e-05,3.651494487380519e-07,1.0954483462141557e-06,"[-1]","Group0",10.833333015441895,13,"[CASP3, EGFR, ICAM1, IL2, LGALS3, MAPK1, MIF, NOS2, NR4A1, PLA2G5, PRKCA, PTGS2, TNF]"]
["WP:15","Selenium Micronutrient Network","WikiPathways_27.02.2019",8.045419196758618e-07,0.00011022224299559306,8.045419196758618e-07,1.6090838393517236e-06,"[-1]","Group1",12.359550476074219,11,"[ALB, ALOX5, F2, ICAM1, MPO, PTGS1, PTGS2, RELA, SERPINE1, TNF, XDH]"]
["WP:3611","Photodynamic therapy-induced AP-1 survival signaling.","WikiPathways_27.02.2019",2.909195304836387e-08,4.276517098109489e-06,2.909195304836387e-08,1.1636781219345548e-07,"[-1]","Group2",19.60784339904785,10,"[BCL2, BCL2L1, EGFR, IL2, JUN, MAPK14, MAPK8, MCL1, NFE2L2, TNF]"]
["WP:3614","Photodynamic therapy-induced HIF-1 survival signaling","WikiPathways_27.02.2019",4.944806512963371e-06,0.0006032663945815313,4.944806512963371e-06,4.944806512963371e-06,"[-1]","Group3",18.91891860961914,7,"[BCL2L1, EGLN1, LDHA, MCL1, NOS2, PTGS2, SERPINE1]"]
["WP:2036","TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway","WikiPathways_27.02.2019",2.0104243040881546e-10,3.11615767133664e-08,8.183362138828483e-13,4.0916810694142416e-12,"[-1]","Group4",26.190475463867188,11,"[CASP3, CASP7, CASP8, CTNNB1, GSK3B, JUN, MAPK1, MAPK14, MAPK8, RELA, TNF]"]
["WP:254","Apoptosis","WikiPathways_27.02.2019",6.263157549266987e-08,9.08157844643713e-06,8.183362138828483e-13,4.0916810694142416e-12,"[-1]","Group4",13.95348834991455,12,"[BCL2, BCL2L1, CASP3, CASP6, CASP7, CASP8, JUN, MCL1, PIK3R1, RELA, TNF, XIAP]"]
["WP:314","Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation","WikiPathways_27.02.2019",6.32290202129722e-09,9.421124011732857e-07,8.183362138828483e-13,4.0916810694142416e-12,"[-1]","Group4",22.727272033691406,10,"[BCL2, CASP3, CASP6, CASP7, CASP8, JUN, MAPK8, MAPKAPK2, PARP1, TNF]"]
["WP:4298","Viral Acute Myocarditis","WikiPathways_27.02.2019",3.9798563200460034e-11,6.248374422472225e-09,8.183362138828483e-13,4.0916810694142416e-12,"[-1]","Group4",17.647058486938477,15,"[BCL2, BCL2L1, CASP3, CASP6, CASP7, CASP8, CCR5, GSK3B, IL2, MAPK1, PABPC1, PARP1, PIK3R1, STAT3, TNF]"]
["WP:2036","TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway","WikiPathways_27.02.2019",2.0104243040881546e-10,3.11615767133664e-08,2.969863621479834e-14,2.0789045350358835e-13,"[-1]","Group5",26.190475463867188,11,"[CASP3, CASP7, CASP8, CTNNB1, GSK3B, JUN, MAPK1, MAPK14, MAPK8, RELA, TNF]"]
["WP:2355","Corticotropin-releasing hormone signaling pathway","WikiPathways_27.02.2019",1.5212430858821154e-10,2.3731392139761e-08,2.969863621479834e-14,2.0789045350358835e-13,"[-1]","Group5",16.129032135009766,15,"[BCL2, CASP3, CTNNB1, ECE1, ERN1, GSK3B, IL2, MAPK1, MAPK14, MAPK8, NR4A1, PARP1, PRKCA, PRKCB, RELA]"]
["WP:2374","Oncostatin M Signaling Pathway","WikiPathways_27.02.2019",2.782625045409405e-09,4.2017638185682014e-07,2.969863621479834e-14,2.0789045350358835e-13,"[-1]","Group5",18.18181800842285,12,"[CASP3, CASP7, MAPK1, MAPK14, MAPK8, PIK3R1, PRKCA, PRKCB, PRKCE, RELA, SERPINE1, STAT3]"]
["WP:304","Kit receptor signaling pathway","WikiPathways_27.02.2019",1.6208957107114087e-06,0.00021233733810319453,2.969863621479834e-14,2.0789045350358835e-13,"[-1]","Group5",15,9,"[BCL2, BTK, MAPK1, MAPK14, MAPK8, PIK3R1, PRKCA, PRKCB, STAT3]"]
["WP:3888","VEGFA-VEGFR2 Signaling Pathway","WikiPathways_27.02.2019",1.0778576811393561e-11,1.7030151362001827e-09,2.969863621479834e-14,2.0789045350358835e-13,"[-1]","Group5",10.084033966064453,24,"[BCL2, BCL2L1, CTNNB1, ERN1, GSK3B, ICAM1, ITGAV, ITGB1, JUN, MAPK1, MAPK14, MAPK8, MAPKAPK2, NR4A1, PIK3CA, PIK3R1, PLA2G5, PRKCA, PRKCB, PRKCE, PTGS2, RELA, SELE, STAT3]"]
["WP:127","IL-5 Signaling Pathway","WikiPathways_27.02.2019",2.303696051639221e-09,3.501617998491616e-07,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",25,10,"[BCL2, BTK, GSK3B, IL2, JUN, MAPK1, PIK3CG, PIK3R1, STAT3, SYK]"]
["WP:1449","Regulation of toll-like receptor signaling pathway","WikiPathways_27.02.2019",5.313237642457584e-07,7.332267946591466e-05,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",9.655172348022461,14,"[BTK, CASP8, JUN, MAPK1, MAPK14, MAPK8, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, RELA, SYK, TNF]"]
["WP:1528","Physiological and Pathological Hypertrophy  of the Heart","WikiPathways_27.02.2019",2.79201341143155e-07,3.936738910118485e-05,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",28,7,"[JUN, MAPK1, MAPK14, MAPK8, PRKCB, PRKCE, STAT3]"]
["WP:1544","MicroRNAs in cardiomyocyte hypertrophy","WikiPathways_27.02.2019",5.882765097605488e-10,9.000630599336396e-08,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",14.70588207244873,15,"[CTNNB1, FGF2, GSK3B, MAPK1, MAPK14, MAPK8, MYLK, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PRKCB, STAT3, TNF]"]
["WP:2018","RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway","WikiPathways_27.02.2019",7.998986740093788e-06,0.0009598784088112545,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",14.545454978942871,8,"[ICAM1, JUN, MAPK1, MAPK14, MAPK8, PIK3R1, RELA, SYK]"]
["WP:2036","TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway","WikiPathways_27.02.2019",2.0104243040881546e-10,3.11615767133664e-08,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",26.190475463867188,11,"[CASP3, CASP7, CASP8, CTNNB1, GSK3B, JUN, MAPK1, MAPK14, MAPK8, RELA, TNF]"]
["WP:2037","Prolactin Signaling Pathway","WikiPathways_27.02.2019",7.257693089369654e-12,1.1539732012097749e-09,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",19.736841201782227,15,"[CASP3, GSK3B, ITGB1, JUN, MAPK1, MAPK14, MAPK8, NOS2, PIK3CA, PIK3CB, PIK3CG, PIK3R1, RELA, STAT3, YWHAG]"]
["WP:2203","Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway","WikiPathways_27.02.2019",2.3470680399195192e-06,0.00030042470910969846,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",17.021276473999023,8,"[BTK, LCK, MAPK1, MAPK14, MAPK8, PIK3CA, RELA, STAT3]"]
["WP:2261","Signaling Pathways in Glioblastoma","WikiPathways_27.02.2019",3.3094168199988587e-06,0.00041036768567985846,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",12.048192977905273,10,"[EGFR, MAPK1, MET, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PRKCA, PRKCB]"]
["WP:23","B Cell Receptor Signaling Pathway","WikiPathways_27.02.2019",2.742579580280457e-07,3.894463003998249e-05,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",12.244897842407227,12,"[BTK, GSK3B, JUN, LCK, MAPK1, MAPK14, MAPK8, PIK3CG, PIK3R1, PRKCB, RELA, SYK]"]
["WP:2324","AGE/RAGE pathway","WikiPathways_27.02.2019",2.0318665711087255e-10,3.1290745195074375e-08,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",19.696969985961914,13,"[CASP3, CASP8, EGFR, JUN, LGALS3, MAPK1, MAPK14, MAPK8, NOS2, PRKCA, PRKCB, RELA, STAT3]"]
["WP:2355","Corticotropin-releasing hormone signaling pathway","WikiPathways_27.02.2019",1.5212430858821154e-10,2.3731392139761e-08,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",16.129032135009766,15,"[BCL2, CASP3, CTNNB1, ECE1, ERN1, GSK3B, IL2, MAPK1, MAPK14, MAPK8, NR4A1, PARP1, PRKCA, PRKCB, RELA]"]
["WP:2374","Oncostatin M Signaling Pathway","WikiPathways_27.02.2019",2.782625045409405e-09,4.2017638185682014e-07,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",18.18181800842285,12,"[CASP3, CASP7, MAPK1, MAPK14, MAPK8, PIK3R1, PRKCA, PRKCB, PRKCE, RELA, SERPINE1, STAT3]"]
["WP:254","Apoptosis","WikiPathways_27.02.2019",6.263157549266987e-08,9.08157844643713e-06,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",13.95348834991455,12,"[BCL2, BCL2L1, CASP3, CASP6, CASP7, CASP8, JUN, MCL1, PIK3R1, RELA, TNF, XIAP]"]
["WP:286","IL-3 Signaling Pathway","WikiPathways_27.02.2019",2.6873745142505355e-07,3.842945555378266e-05,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",18.367347717285156,9,"[BCL2, BCL2L1, JUN, MAPK1, MAPK8, PIK3CD, PIK3R1, STAT3, SYK]"]
["WP:304","Kit receptor signaling pathway","WikiPathways_27.02.2019",1.6208957107114087e-06,0.00021233733810319453,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",15,9,"[BCL2, BTK, MAPK1, MAPK14, MAPK8, PIK3R1, PRKCA, PRKCB, STAT3]"]
["WP:306","Focal Adhesion","WikiPathways_27.02.2019",3.8545345189011246e-08,5.6276203975956415e-06,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",8.91089153289795,18,"[BCL2, CTNNB1, EGFR, GSK3B, ITGAV, ITGB1, JUN, MAPK1, MAPK8, MET, MYLK, PIK3CA, PIK3CB, PIK3CD, PIK3R1, PRKCA, PRKCB, XIAP]"]
["WP:313","Signaling of Hepatocyte Growth Factor Receptor","WikiPathways_27.02.2019",2.70941955264124e-06,0.00034138686363279625,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",20.58823585510254,7,"[ITGB1, JUN, MAPK1, MAPK8, MET, PIK3CA, STAT3]"]
["WP:314","Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation","WikiPathways_27.02.2019",6.32290202129722e-09,9.421124011732857e-07,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",22.727272033691406,10,"[BCL2, CASP3, CASP6, CASP7, CASP8, JUN, MAPK8, MAPKAPK2, PARP1, TNF]"]
["WP:3303","RAC1/PAK1/p38/MMP2 Pathway","WikiPathways_27.02.2019",4.747761354745786e-09,7.121642032118679e-07,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",17.39130401611328,12,"[CASP7, CTNNB1, EGFR, ITGB1, MAPK1, MAPK14, MAPK8, NOS2, PIK3CA, PIK3R1, RELA, STAT3]"]
["WP:3646","Hepatitis C and Hepatocellular Carcinoma","WikiPathways_27.02.2019",2.3767068780883925e-08,3.517526179570821e-06,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",20,10,"[BCL2L1, CASP3, CASP7, CXCR1, JUN, MAPK14, MAPK8, NOS2, PTGS2, STAT3]"]
["WP:3972","PDGFR-beta pathway","WikiPathways_27.02.2019",8.508563006944933e-07,0.00011571645689445108,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",24.13793182373047,7,"[JUN, MAPK8, PIK3CA, PIK3R1, PRKCA, PRKCB, STAT3]"]
["WP:4155","Endometrial cancer","WikiPathways_27.02.2019",2.4731408592306473e-06,0.0003140888891222922,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",14.285714149475098,9,"[CTNNB1, EGFR, FGF2, GSK3B, MAPK1, PIK3CA, PIK3CB, PIK3CD, PIK3R1]"]
["WP:4172","PI3K-Akt Signaling Pathway","WikiPathways_27.02.2019",1.7694486064656393e-06,0.00023002831884053312,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",6.08695650100708,21,"[BCL2, BCL2L1, EGFR, FGF2, FLT3, GSK3B, IL2, ITGAV, ITGB1, MAPK1, MCL1, MET, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PKN1, PRKCA, RELA, SYK]"]
["WP:4205","MET in type 1 papillary renal cell carcinoma","WikiPathways_27.02.2019",1.4000380282927719e-06,0.0001848050197346459,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",15.254237174987793,9,"[JUN, MAPK1, MAPK8, MET, PIK3CA, PIK3CB, PIK3CD, PIK3R1, STAT3]"]
["WP:4217","Ebola Virus Pathway on Host","WikiPathways_27.02.2019",1.1069942075878193e-06,0.00014723022960917996,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",9.848484992980957,13,"[ADAM17, CTSB, CTSL, EGFR, ITGAV, ITGB1, MAPK1, PIK3CA, PIK3CB, PIK3CD, PIK3R1, RELA, TOP1]"]
["WP:4223","Ras Signaling","WikiPathways_27.02.2019",2.072113978830087e-06,0.00026730270326908123,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",8.064516067504883,15,"[BCL2L1, EGFR, FLT3, MAPK1, MAPK8, MET, PIK3CA, PIK3CB, PIK3CD, PIK3R1, PLA2G1B, PLA2G5, PRKCA, PRKCB, RELA]"]
["WP:4255","Non-small cell lung cancer","WikiPathways_27.02.2019",3.6861124457527056e-06,0.00045339183082758277,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",13.636363983154297,9,"[EGFR, MAPK1, PIK3CA, PIK3CB, PIK3CD, PIK3R1, PRKCA, PRKCB, STAT3]"]
["WP:4263","Pancreatic adenocarcinoma pathway","WikiPathways_27.02.2019",6.282248903580196e-06,0.0007601521173332037,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",11.235955238342285,10,"[BCL2L1, EGFR, MAPK1, MAPK8, PIK3CA, PIK3CB, PIK3CD, PIK3R1, RELA, STAT3]"]
["WP:4481","Resistin as a regulator of inflammation","WikiPathways_27.02.2019",1.2958848872151633e-07,1.8660742375898352e-05,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",24.24242401123047,8,"[MAPK1, MAPK14, PIK3CA, PIK3CB, PIK3CD, PIK3CG, RELA, TNF]"]
["WP:49","IL-2 Signaling Pathway","WikiPathways_27.02.2019",9.541483134081025e-07,0.00012881002231009383,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",19.047618865966797,8,"[BCL2, IL2, JUN, LCK, MAPK1, PIK3R1, STAT3, SYK]"]
["WP:673","ErbB Signaling Pathway","WikiPathways_27.02.2019",1.0095386771317223e-06,0.0001352781827356508,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",12.087912559509277,11,"[EGFR, GSK3B, JUN, MAPK1, MAPK8, PIK3CA, PIK3CB, PIK3CD, PIK3R1, PRKCA, PRKCB]"]
["WP:712","Estrogen signaling pathway","WikiPathways_27.02.2019",3.2913166055934717e-06,0.00041141457569918394,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",26.086956024169922,6,"[BCL2, ESR1, JUN, MAPK1, MAPK14, PIK3CA]"]
["WP:75","Toll-like Receptor Signaling Pathway","WikiPathways_27.02.2019",5.29832786070325e-07,7.364675726377518e-05,5.020672860013052e-13,3.012403716007831e-12,"[-1]","Group6",11.538461685180664,12,"[CASP8, JUN, MAPK1, MAPK14, MAPK8, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, RELA, TNF]"]